Japanese
sitemap
contact us
January 28, 2009
Kringle Pharma and Maruho Agreed to Conclude an Option Agreement
for ChronSeal
®
.
January 28, 2009
Kringle Pharma Commences a Phase I/II Clinical Trial in Sweden on ChronSeal
®
,
a Recombinant Human HGF-Based Therapy for
the Treatment of Skin Ulcers.
December 17, 2008
Kringle Pharma Europe AB Established in Sweden.
Copyright (C)2004 Kringle Pharma, Inc. All rights reserved.
January 28, 2009